NCT02658214 2020-08-20Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsAstraZenecaPhase 1 Completed32 enrolled
NCT02069158 2019-05-21IOSI-NDU-001Oncology Institute of Southern SwitzerlandPhase 1 Completed17 enrolled